Developmental exposure to xenoestrogens at low doses alters femur length and tensile strength in adult mice

Biology of Reproduction

Volumn 86, Issue 3, 2012, Pages

  Pelch, Katherine E ^a   Carleton, Stephanie M ^a   Phillips, Charlotte L ^a   Nagel, Susan C ^a  

^a University of Missouri   (United States)

Author keywords

Bone; Developmental origins of health and disease; Endocrine disruptors; Environmental contaminants and toxicants; Estradiol; Estradiol receptor

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; COLLAGEN; DIETHYLSTILBESTROL; ETHINYLESTRADIOL; PHENOL DERIVATIVE;

ADULTHOOD; ANIMAL EXPERIMENT; ARTICLE; BONE STRENGTH; CONTROLLED STUDY; DOSE RESPONSE; ENERGY; FEMALE; FEMUR; GEOMETRY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSMOTIC PUMP; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; PRIORITY JOURNAL; TENSILE STRENGTH; ANIMAL; ANIMAL MODEL; BIOMECHANICS; C57BL MOUSE; DRUG EFFECT; FETUS DEVELOPMENT; HISTOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION; PREGNANCY; PRENATAL DEVELOPMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

MUS;

ADMINISTRATION, ORAL; ANIMALS; BIOMECHANICS; COLLAGEN; DIETHYLSTILBESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHINYL ESTRADIOL; FEMALE; FEMUR; FETAL DEVELOPMENT; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PHENOLS; PREGNANCY; TENSILE STRENGTH;

EID: 84860621651     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.096545     Document Type: Article

References (59)

1. Cerel-Suhl SL, Yeager BF. Update on oral contraceptive pills. Am Fam Physician 1999; 60:2073-2084.
2. Falconer IR, Chapman HF, Moore MR, Ranmuthugala G. Endocrinedisrupting compounds: a review of their challenge to sustainable and safe water supply and water reuse. Environ Toxicol 2006; 21:181-191.
3. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002; 36:1202-1211.
4. Rosenfeldt EJ, Linden KG. Degradation of endocrine disrupting chemicals bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation processes. Environ Sci Technol 2004; 38:5476-5483.
5. Bisphenol A frequently asked questions from the Polycarbonate/BPA Global Group, American Chemistry Council, Washington, DC. 2010. World Wide Web (URL: http://www.bisphenol-a.org/about/faq.html#c). (22 September 2010).
6. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 1995; 103:608-612.
7. Olea N, Pulgar R, Perez P, Olea-Serrano F, Rivas A, Novillo-Fertrell A, Pedraza V, Soto AM, Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 1996;104:298-305.
8. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993; 132:2279-2286.
9. Biedermann S, Tschudin P, Grob K. Transfer of bisphenol A from thermal printer paper to the skin. Anal Bioanal Chem 2010; 398:571-576.
10. Mendum T, Stoler E, VanBenschoten H, Warner JC. Concentration of bisphenol A in thermal paper. Green Chem Lett Rev 2011; 4:81-86.
11. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24:139-177.
12. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008; 116:39-44.
13. Stahlhut RW, Welshons W, Swan S, Bisphenol A. Data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect 2009; 117:784-789.
14. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrinedisrupting chemicals in wildlife and humans. Environ Health Perspect 1993; 101:378-384.
15. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 284:878-881.
16. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB, Hunter DJ. In utero exposures and the incidence of endometriosis. Fertil Steril 2004; 82:1501-1508.
17. Xue F, Michels KB. Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence. Lancet Oncol 2007; 8:1088-1100.
18. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006; 116:561-570.
19. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138:863-870.
20. Matthews JB, Twomey K, Zacharewski TR. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol 2001; 14:149-157.
21. Takemura H, Ma J, Sayama K, Terao Y, Zhu BT, Shimoi K. In vitro and in vivo estrogenic activity of chlorinated derivatives of bisphenol A. Toxicology 2005; 207:215-221.
22. Migliaccio S, Newbold RR, Bullock BC, McLachlan JA, Korach KS. Developmental exposure to estrogens induces persistent changes in skeletal tissue. Endocrinology 1992; 130:1756-1758.
23. Fukazawa Y, Nobata S, Katoh M, Tanaka M, Kobayashi S, Ohta Y, Hayashi Y, Iguchi T. Effect of neonatal exposure to diethylstilbestrol and tamoxifen on pelvis and femur in male mice. Anat Rec 1996; 244:416-422.
24. Piekarz AV, Ward WE. Effect of neonatal exposure to genistein on bone metabolism in mice at adulthood. Pediatr Res 2007; 61:48-53.
25. Kaludjerovic J, Ward WE. Diethylstilbesterol has gender-specific effects on weight gain and bone development in mice. J Toxicol Environ Health A 2008; 71:1032-1042.
26. Kaludjerovic J, Ward WE. Neonatal exposure to daidzein, genistein, or the combination modulates bone development in female CD-1 mice. J Nutr 2009; 139:467-473.
27. Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press; 1996.
28. Ferguson VL, Ayers RA, Bateman TA, Simske SJ. Bone development and age-related bone loss in male C57BL/6J mice. Bone 2003; 33:387-398.
29. Klein RF, Mitchell SR, Phillips TJ, Belknap JK, Orwoll ES. Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res 1998; 13:1648-1656.
30. Carleton SM, McBride DJ, Carson WL, Huntington CE, Twenter KL, Rolwes KM, Winkelmann CT, Morris JS, Taylor JF, Phillips CL. Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim). Bone 2008; 42:681-694.
31. Roarck RJ, Young WC. Formulas for stress and strain. In: Formulas for Stress and Strain, 5th ed. New York: McGraw-Hill; 1975.
32. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93:440-447.
33. Stegemann H, Stalder K. Determination of hydroxyproline. Clin Chim Acta 1967; 18:267-273.
34. Clode SA. Assessment of in vivo assays for endocrine disruption. Best Pract Res Clin Endocrinol Metab 2006; 20:35-43.
35. Burr DB. The contribution of the organic matrix to bone's material properties. Bone 2002; 31:8-11.
36. Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev 2011;4:CD003989.
37. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118:1055-1070.
38. Prins GS, Ye SH, Birch L, Ho SM, Kannan K. Serum bisphenol A pharmacokinetics and prostate neoplastic responses following oral and subcutaneous exposures in neonatal Sprague-Dawley rats. Reprod Toxicol 2011; 31:1-9.
39. Smith OW. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am J Obstet Gynecol 1948; 56:821-834.
40. Labarthe D, Adam E, Noller KL, O'Brien PC, Robboy SJ, Tilley BC, Townsend D, Barnes AB, Kaufman RH, Decker DG, Fish CR, Herbst AL, et al. Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 1978;51:453-458.
41. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995; 122:778-788.
42. Honma S, Suzuki A, Buchanan DL, Katsu Y, Watanabe H, Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol 2002; 16:117-122.
43. Migliaccio S, Newbold RR, Bullock BC, Jefferson WJ, Sutton FG Jr, McLachlan JA, Korach KS. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring. Endocrinology 1996;137:2118-2125.
44. Migliaccio S, Newbold RR, McLachlan JA, Korach KS. Alterations in estrogen levels during development affects the skeleton: use of an animal model. Environ Health Perspect 1995; 103(suppl 7):95-97.
45. Migliaccio S, Newbold RR, Teti A, Jefferson WJ, Toverud SU, Taranta A, Bullock BC, Suggs CA, Spera G, Korach KS. Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood. Bone 2000; 27:47-52.
46. Hotchkiss CE, Weis C, Blaydes B, Newbold R, Delclos KB. Multigenerational exposure to ethinyl estradiol affects bone geometry, but not bone mineral density in rats. Bone 2008; 43:110-118.
47. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS. Large effects from small exposures. I. Mechanisms for endocrinedisrupting chemicals with estrogenic activity. Environ Health Perspect 2003; 111:994-1006.
48. Frost HM. Muscle, bone, and the Utah paradigm: a 1999 overview. Med Sci Sports Exerc 2000; 32:911-917.
49. Turner CH. Bone strength: current concepts. Ann N Y Acad Sci 2006;1068:429-446.
50. Turner CH, Robling AG. Mechanisms by which exercise improves bone strength. J Bone Miner Metab 2005; 23 Suppl:16-22.
51. Warden SJ, Hurst JA, Sanders MS, Turner CH, Burr DB, Li J. Bone adaptation to a mechanical loading program significantly increases skeletal fatigue resistance. J Bone Miner Res 2005; 20:809-816.
52. Phillips CL, Bradley DA, Schlotzhauer CL, Bergfeld M, Libreros-Minotta C, Gawenis LR, Morris JS, Clarke LL, Hillman LS. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone 2000; 27:219-226.
53. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993; 341:72-75.
54. Huang C, Ross PD, Wasnich RD. Short-term and long-term fracture prediction by bone mass measurements: a prospective study. J Bone Miner Res 1998; 13:107-113.
55. Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects. J Bone Miner Res 2010; 25:190-199.
56. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 2000; 54:154-167.
57. Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol Lett 2006; 167:95-105.
58. Bonnelye E, Vanacker JM, Spruyt N, Alric S, Fournier B, Desbiens X, Laudet V. Expression of the estrogen-related receptor 1 (ERR-1) orphan receptor during mouse development. Mech Dev 1997; 65:71-85.
59. Lemmen JG, Broekhof JL, Kuiper GG, Gustafsson JA, van der Saag PT, van der Burg B. Expression of estrogen receptor alpha and beta during mouse embryogenesis. Mech Dev 1999; 81:163-167.